In plants, the only known outer-chain elongation of complex N-glycans is the formation of Lewis a [Fuca1-4(Galb1-3) GlcNAc-R] structures. This process involves the sequential attachment of b1,3-galactose and a1,4-fucose residues by b1,3-galactosyltransferase and a1,4-fucosyltransferase. However, the exact mechanism underlying the formation of Lewis a epitopes in plants is poorly understood, largely because one of the involved enzymes, b1,3-galactosyltransferase, has not yet been identified and characterized. Here, we report the identification of an Arabidopsis thaliana b1,3-galactosyltransferase involved in the biosynthesis of the Lewis a epitope using an expression cloning strategy. Overexpression of various candidates led to the identification of a single gene (named GALACTOSYLTRANSFERASE1 [GALT1]) that increased the originally very low Lewis a epitope levels in planta. Recombinant GALT1 protein produced in insect cells was capable of transferring b1,3-linked galactose residues to various N-glycan acceptor substrates, and subsequent treatment of the reaction products with a1,4-fucosyltransferase resulted in the generation of Lewis a structures. Furthermore, transgenic Arabidopsis plants lacking a functional GALT1 mRNA did not show any detectable amounts of Lewis a epitopes on endogenous glycoproteins. Taken together, our results demonstrate that GALT1 is both sufficient and essential for the addition of b1,3-linked galactose residues to N-glycans and thus is required for the biosynthesis of Lewis a structures in Arabidopsis. Moreover, cell biological characterization of a transiently expressed GALT1-fluorescent protein fusion using confocal laser scanning microscopy revealed the exclusive location of GALT1 within the Golgi apparatus, which is in good agreement with the proposed physiological action of the enzyme.
INTRODUCTION
N-glycosylation is a major posttranslational modification of proteins in all eukaryotic cells. While the early processing steps of protein-bound N-linked oligosaccharides (N-glycans) that take place in the endoplasmic reticulum (ER) and Golgi apparatus are conserved between animals and plants, the later steps of N-glycan maturation differ significantly. Plant glycoproteins contain two major types of oligosaccharides: paucimannosidic and complex N-glycans (Figure 1 ) (Lerouge et al., 1998; Wilson et al., 2001b) . Most of these plant N-glycans carry b1,2-xylose and core a1,3-fucose as well as up to two terminal N-acetylglucosamine (GlcNAc) residues attached to the pentasaccharide (Man 3 GlcNAc 2 ) core structure. b1,2-xylose and core a1,3-fucose residues are absent in mammalian glycoproteins. Furthermore, plant glycoproteins differ from mammalian ones as they are devoid of b1,4-linked galactose (Bakker et al., 2001b) , sialic acid (Sé veno et al., 2004; Zeleny et al., 2006) , and further branching, which results in considerably less N-glycan heterogeneity. In plants, the only known outer-chain elongation of N-glycans is the attachment of b1,3-galactose (Gal) and a1,4-fucose (Fuc) residues, which form a trisaccharide [Fuca1-4(Galb1-3)GlcNAc-R] known as the Lewis a (Le a ) epitope (Fitchette-Lainé et al., 1997; Melo et al., 1997) (Figure 1 ). The Le a epitope was detected on glycoproteins from many different plant species (Fitchette et al., 1999; Wilson et al., 2001b) . Le a structures were found primarily on soluble and membrane-bound extracellular proteins and were reported as absent from vacuolar proteins (Fitchette-Lainé et al., 1997; Melo et al., 1997; Fitchette et al., 1999) . Although Le a structures are otherwise widespread in the plant kingdom, most studies have failed to detect Le a containing N-glycans in Arabidopsis thaliana and other Brassicaceae (e.g., Fitchette-Lainé et al., 1997; Wilson et al., 2001b) , with two exceptions where Le a epitopes were detected by immunological means in Arabidopsis root tips and seedlings, respectively (Jin et al., 2001; Lé onard et al., 2002) .
Most steps of the N-glycosylation pathway in plants are well characterized (see Supplemental Figure 1 online). The enzymes that are responsible for the addition of outer-chain GlcNAc residues, b1,2-N-acetylglucosaminyltransferase I (Strasser et al., 1999a) and b1,2-N-acetylglucosaminyltransferase II (Strasser et al., 1999b) , and the attachment of b1,2-linked xylose and core a1,3-linked fucose residues, b1,2-xylosyltransferase (Strasser et al., 2000) and core a1,3-fucosyltransferase (Leiter et al., 1999) , have been cloned and characterized. It has been proposed that two enzymes are required for the synthesis of the Le a epitope on complex plant N-glycans. First, a b1,3-galactosyltransferase transfers a galactose to a terminal GlcNAc residue in b1,3-linkage, resulting in the synthesis of type 1 chain structures (Galb1-3GlcNAc), and then an a1,4-fucosyltransferase (FUT13; FucTC) transfers fucose in a1,4-linkage to the GlcNAc of the type 1 chain to complete the synthesis of the Le a structure. FUT13 has been cloned from several plant species, and its enzymatic activity has been characterized. FUT13 has a strict acceptor substrate specificity for type 1 chain-based glycan structures, whereas type 2 chains (Galb1-4GlcNAc), which are typical for mammalian N-linked glycans, are not used (Bakker et al., 2001a; Wilson, 2001a; Palma et al., 2001; Lé onard et al., 2002 Lé onard et al., , 2005a . However, the b1,3-galactosyltransferase involved in Le a biosynthesis has not been characterized so far.
In this study, we reinvestigated the occurrence of Le a structures in Arabidopsis tissues and provide compelling evidence that at least certain organs contain glycoproteins with Le a structures. Using an expression cloning strategy, we were able to identify a single gene (GALACTOSYLTRANSFERASE1 [GALT1]), out of six candidate genes, that codes for the Arabidopsis b1,3-galactosyltransferase involved in Le a biosynthesis. Overexpression of GALT1 in Arabidopsis increased the Le a epitope levels in planta, whereas a knockout of the GALT1 gene or its selective downregulation by RNA interference abolished the synthesis of Le a structures. Recombinant GALT1 produced in insect cells was used to determine the enzymatic properties of the enzyme, and a transiently expressed GALT1-green fluorescent protein (GFP) fusion was used to investigate its subcellular localization.
RESULTS

Expression of Le a Epitopes in Arabidopsis
Although Le a structures have been detected on glycoproteins from various plant species, this oligosaccharide structure was initially reported to be absent from Arabidopsis and other members of the Brassicaceae (Fitchette-Lainé et al., 1997; Rayon et al., 1999; Wilson et al., 2001b) . However, in a later study, the epitope was detected in Arabidopsis seedlings by immunoblots using Le a -specific antibodies (Lé onard et al., 2002) . To address these conflicting results, we performed a systematic analysis of N-glycans present in different organs of Arabidopsis. Total protein extracts were analyzed by immunoblots using JIM84 (Horsley et al., 1993) , a monoclonal antibody specifically binding to Le a structures on plant N-glycans (Fitchette et al., 1999) . We found that the Le a epitope is not detectable in leaves but is clearly present in pedicels, stems, and nodes and to a lesser extent in siliques, shoot apex, flowers, and roots ( Figure 2A ). Proteins extracted from cgl1 plants, which do not produce complex N-glycans (von Schaewen et al., 1993; Strasser et al., 2005) , did not show any signal, indicating that the epitope is exclusively present on N-glycans (see Supplemental Figure 2 online). To further investigate the N-glycan composition of individual Arabidopsis tissues, matrix-assisted laser-desorption ionization time of flight mass spectrometry (MALDI-TOF MS) analyses were performed using N-glycans present in total protein extracts from various organs. The mass spectra of leaf N-glycans contained three major peaks. These three peaks were assigned to the typical paucimannosidic structure MMXF and the complex-type N-glycans GnMXF/MGnXF and GnGnXF ( Figure 4B ; Strasser et al., 2004a) . These peaks were also the predominant structures in the mass spectra of stem-derived N-glycans. Notably, stem samples contained a small but distinct peak with a mass of 2234.8 D corresponding to the Le a -containing N-glycan structure (FA)(FA)XF and a second peak with one galactose and one outer-chain fucose residue [(FA)GnXF, mass-to-charge ratio (m/z) ¼ 1926.7; Figure 2B ]. These results are in good agreement with the immunoblot data and clearly indicate the presence of Le a epitopes in Arabidopsis stems.
Gene Identification
A BLASTP search in The Arabidopsis Information Resource database (http://www.arabidopsis.org/; data set: AGI proteins) was performed using amino acid sequences from murine and human b1,3-galactosyltransferases (B3GALTs; see Supplemental Table 1 online), which have been shown to act on N-glycans (Amado et al., 1998; Zhou et al., 1999; Holgersson and Lö fling, 2006) . Six Arabidopsis proteins (gene identifiers: At1g26810, At1g27120, At1g74800, At3g06440, At4g21060, and At5g62620; see Supplemental Table 2 online) with significant amino acid sequence similarity to mammalian B3GALTs (23 to 31% identity/ 45 to 55% similarity) could be identified. Like the mammalian B3GALTs, all six Arabidopsis proteins contain a conserved galactosyltransferase sequence domain (pfam 01762) and are annotated as members of glycosyltransferase family GT31 in the CAZy database (http://afmb.cnrs-mrs.fr/CAZY/). Family GT31 Characteristic plant N-glycan structures are shown. The paucimannosidic structure MMXF (for nomenclature, see www.proglycan.com and Supplemental Figure 5 online), which lacks terminal GlcNAc residues at the nonreducing ends, and the complex N-glycan GnGnXF are the major N-glycan species identified in plants. The Le a structure (FA)(FA)XF represents the most sophisticated complex plant N-glycan structure so far.
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The Plant Cell contains 32 Arabidopsis sequences. Out of these, 20 proteins contain the galactosyltransferase domain (pfam 01762; see Supplemental Table 1 online) . Phylogenetic analysis of the 20 Arabidopsis proteins and mammalian GALTs revealed that the six initially identified proteins indeed cluster together and form a small subfamily (subfamily 1; Figure 3A ). Within subfamily 1, the Arabidopsis proteins display 40 to 73% identity (59 to 84% similarity) to each other, and the B3GALT motifs (Hennet, 2002) are found in all of them. Amino acid sequences from members of subfamily 1 were run through several prediction programs (TargetP, http://www. cbs.dtu.dk/services/TargetP/; Predotar, http://genoplante-info. infobiogen.fr/predotar/predotar.html; iPSORT, http://hc.ims. u-tokyo.ac.jp/iPSORT/) to obtain information on their putative subcellular localization and topology. Based on these predictions, all six proteins should be targeted to the secretory pathway and all of them are predicted to have a single transmembrane domain. Interestingly, all members of subfamily 1 contain in addition to the galactosyltransferase domain another conserved Protein gel blot analysis and mass spectrometry of N-glycans were performed to detect the Le a carbohydrate epitope in individual Arabidopsis tissues. (A) Proteins were extracted from different organs, and 12 mg of total protein were subjected to SDS-PAGE under reducing conditions. Immunoblotting was performed using JIM84 antibodies. fl, flowers; pe, pedicels; si, siliques; st, stem; n, node; sa, shoot apex; cl, cauline leaves; jl, juvenile leaves; al, adult leaves, p, petiole; sl, senescent leaves; r, roots. (A) Phylogenetic analysis of putative Arabidopsis GALT proteins was conducted using MEGA version 3.1. Amino acid sequences of the 20 pfam 01762-containing Arabidopsis proteins from CAZy glycosyltransferase family GT31 and three mammalian B3GALTs (Mm-B3GALT1, UniProt accession number O54904; Hs-B3GALT2, O43825; and Hs-B3GALT5, Q9BYG0) were aligned using ClustalW. The phylogenetic tree was constructed with the neighbor-joining method, and the bootstrap values were determined from 1000 trials. The percentages of bootstrap values for the respected branches are shown. The members of subfamily 1 are highlighted in gray. Bar ¼ 20% divergence. (B) Expression analysis of GALT candidate genes by RT-PCR. RT-PCR was performed with specific primers for the respective genes from subfamily 1 or ubiquitin (UBQ5) and core a1,3-fucosyltransferase (FucTB) as controls (35 PCR cycles for all reactions). Siliques (si), stems (st), cauline leaves (cl), and juvenile leaves (jl) were analyzed. All RT-PCR reactions were performed twice with similar results. Based on the data from the Le a immunoblots, we reasoned that the expression of the responsible GALT gene(s) might be upregulated in tissues showing a strong Le a signal. To investigate this, the transcript levels of the six candidate genes were monitored in siliques, stems, and two types of leaves using RT-PCR. All six putative GALT mRNAs were detected in the four organs ( Figure 3B ), although at various levels. Two of them, At1g26810 and At4g21060, displayed higher transcript levels in stems than in leaves. The difference in transcript levels between stems and leaves was most pronounced for At1g26810. Hence, the open reading frame of this GALT candidate gene was expressed in Arabidopsis under the control of the cauliflower mosaic virus 35S promoter, and leaves of these transgenic plants were screened with JIM84 for the presence of the Le a epitope. As a control for this expression cloning strategy, additional transgenic Arabidopsis plants carrying either mouse b1,3-galactosyltransferase 1 (Mm-B3GALT1) or Arabidopsis FUT13 cDNAs were generated. For all transgenic plants, integration of the heterologous construct was confirmed by PCR from genomic DNA, and its transcription verified by RT-PCR. To investigate the presence or absence of Le a structures in the transgenic lines, total protein extracts from leaves were immunoblotted with JIM84 antibodies. While the 35S:FUT13 plants did not show any increase in the intensity of the Le a signal, plants expressing the 35S:Mm-B3GALT1 construct clearly did (see Supplemental Figure 3 online). This indicates that acceptor and donor substrates for the formation of Le a epitopes are available in leaves and demonstrates that the endogenous activity of FUT13 is not limiting. Interestingly, At1g26810 overexpression resulted in a strong signal ( Figure 4A ) comparable to the one found in 35S: Mm-B3GALT1 plants. By contrast, expression of At1g27120, At1g74800, At3g06440, At4g21060, and At5g62620 cDNAs did not lead to any increase of JIM84 staining, indicating that these proteins are not involved in the formation of Le a epitopes (see Supplemental Figure 3 online). In contrast with the N-glycan spectrum of leaves from untransformed plants, MALDI-TOF MS analysis of total N-glycans isolated from leaves of the transgenic 35S:At1g26810 plants showed the presence of peaks representing N-glycans with Le a structures ( Figure 4B ). Hence, At1g26810 encodes a b1,3-galactosyltransferase (GALT1) capable of mediating the formation of Le a epitopes in Arabidopsis. We therefore decided to focus on At1g26810 and named this gene GALT1.
The sequence of the GALT1 open reading frame has a size of 1932 bp and codes for a protein of 643 amino acids, with a calculated molecular mass of 72.3 kD and a theoretical isoelectric point of 5.0. Apart from a silent base pair change (at position 1206: ''G'' instead of ''A''), the isolated cDNA is identical to the seven exons of the annotated genomic sequence. The 59-rapid amplification of cDNA ends (59-RACE) revealed a 59-untranslated region of 248 bp without any additional translation initiation start site. A hydrophobic sequence is located at the N terminus ( Figure  5 ), which suggests that GALT1 has a type II membrane protein topology with a single transmembrane domain and a short 
The Plant Cell cytoplasmic tail as typical for Golgi-located glycosyltransferases. An alignment of the galactosyltransferase domain sequences of GALT1 and mammalian B3GALTs reveals a number of highly conserved residues putatively involved in substrate binding and catalysis (see Supplemental Figure 4 online).
Comparison of GALT1 with sequences from rice (Oryza sativa) revealed two proteins (UniProt identifiers Q67X53 and Q69JV6) with >50% overall identity and >70% identity in the putative galactosyltransferase domain. Sequences with pronounced similarity to GALT1 are present in EST collections from various other plant species, for example, Solanum lycopersicum (AI490537), Glycine max (BM085070), Gossypium raimondii (CO127496), Euphorbia esula (DV149309), Populus trichocarpa (DT473521), Phaseolus vulgaris (CV532292), Triticum aestivum (CJ656647), Vitis vinifera (DT008912), and Malus domestica (CO903688).
Heterologous Expression of GALT1 in Insect Cells
A soluble secreted form of GALT1 was produced by baculovirusmediated infection of Spodoptera frugiperda Sf21 insect cells, and recombinant GALT1 protein was purified from culture supernatants by means of nickel-chelate affinity chromatography. Immunoblotting with antibodies to the enterokinase cleavage site present in the recombinant fusion protein revealed a major immunoreactive band of ;80 kD ( Figure 6A ), which is in good agreement with its theoretical molecular mass (73.2 kD), considering that the protein contains seven potential N-glycosylation sites. PNGase F digestion led to a 73-kD band, indicating that recombinant GALT1 is indeed N-glycosylated.
To test for galactosyltransferase activity, purified GALT1 was incubated with a glycopeptide acceptor substrate (dabsylated GnGn-peptide, m/z ¼ 2061; see Supplemental Figure 5 online for nomenclature and structures of N-glycans) and UDP-galactose as a donor substrate. The assays were analyzed by MALDI-TOF MS ( Figure 6B ) and clearly revealed peaks with mass increases of 162 and 324 D, representing monogalactosylated (m/z ¼ 2223) and digalactosylated (m/z ¼ 2385) reaction products. This demonstrates that recombinant Arabidopsis GALT1 is a functional galactosyltransferase capable of acting on N-glycans.
Characterization of Galactosyltransferase Activity
To make a detailed analysis of the linkage that is created by GALT1, activity assays were performed with the oligosaccharide substrate GnGn-PA. The samples were subsequently subjected to HPLC analysis using a novel graphitized fractionation matrix to obtain clean separation of substrate and product peaks. Three product peaks eluting clearly after the substrate GnGn-PA were detected ( Figure 6C ). The peaks from the GALT1 sample coeluted with the ones from a control reaction (A 3 Gn-, GnA 3 -, and A 3 A 3 -PA) using recombinant Mm-B3GALT1. In addition, digestion of the GALT1 products with Xanthomonas manihotis b1,3-galactosidase led to a shift of the corresponding peaks to the elution position of the GnGn-PA substrate ( Figure 6D ). By contrast, incubation with Aspergillus oryzae b-galactosidase, which is known to remove b1,4-linked and b1,6-linked galactose (Zeleny et al., 1997) , did not result in any detectable shift of peaks. These data demonstrate that GALT1 is a b1,3-galactosyltransferase acting on N-glycan substrates. The specific activity with GnGn-PA as substrate was 3.1 6 0.3 pmol/min/mg of GALT1 protein. No galactosyltransferase activity was detected in the absence of manganese ions or in the presence of EDTA (see Supplemental Figure 6 online), which indicates that GALT1 is, like the mammalian B3GALTs, a strictly metal ion-dependent enzyme, in agreement with the presence of a DXD motif ( Figure 5 ) presumably involved in binding of the metal ion and the donor substrate.
To see whether the product of GALT1 action is indeed a substrate for FUT13, dabsylated GnGn-peptide (m/z ¼ 2061) was sequentially incubated with GALT1 and FUT13 in the presence of the respective nucleotide sugar donor substrates, UDPgalactose and GDP-fucose. For this purpose, FUT13 was also expressed as a secreted soluble form in insect cells and purified using nickel-chelate affinity chromatography. MALDI-TOF MS analysis of the reaction products revealed the presence of peaks with masses indicative of the addition of either one [(FA)Gn/ Gn(FA)] or two [(FA)(FA)] galactose and fucose units ( Figure 7A ). To show that GALT1 can act on glycoprotein substrates, a glycovariant of human transferrin lacking sialic acid and galactose residues (GnGn-Tf) was sequentially incubated with GALT1 and FUT13 and then subjected to immunoblotting with JIM84. GnGn-Tf thus treated reacted with anti-Le a antibodies ( Figure  7B ), while control samples did not show a transferrin signal. Interestingly, apart from the transferrin band (70 kD), another major band of ;80 kD was visible in samples incubated with The putative transmembrane domain (amino acids 6 to 23) predicted by HmmTOP_V2 (http://www.enzim.hu/hmmtop/index.html) is highlighted in gray, and putative N-glycosylation sites are underlined. The galactoside binding lectin domain (pfam 00337) is shown in italics, and the galactosyltransferase domain (pfam 01762) is shown in bold. The conserved DXD motif is shaded black, and the asterisk marks the beginning of the fragment that was expressed in insect cells as a soluble secreted form.
b1,3-GalactosyltransferaseFUT13. This band was identified as GALT1 itself. Since endogenous and heterologous glycoproteins synthesized by Sf21 cells usually lack N-glycans with terminal galactose residues (e.g., Kubelka et al., 1994; Bencú r et al., 2005) , we concluded that GALT1 is capable of autogalactosylation during its production in these cells. In Figure 7B , the autogalactosylation of GALT1 was only detectable upon further incubation with recombinant FUT13 in the presence of the donor substrate GDP-fucose. The corresponding band in lanes 2 and 3 did not give a signal because GDP-fucose (lane 2, left panel) and GDP-fucose/FUT13 (lane 3, left panel) were missing in the assay.
To confirm the modification of GALT1 N-glycans with b1,3-linked galactose residues, GALT1 was first treated with X. manihotis b1,3-galactosidase or A. oryzae b1,4/b1,6-galactosidase and then incubated with FUT13 and GDP-fucose. Subsequent analysis by immunoblotting using JIM84 antibodies did not give any signal in the b1,3-galactosidase-treated GALT1 sample, while treatment of GALT1 with A. oryzae b-galactosidase did not affect the formation of Le a epitopes ( Figure 8A ). The presence of galactose residues on N-glycans of recombinantly produced GALT1 was also confirmed by analysis of tryptic digests using liquid chromatography-mass spectrometry (LC-MS). Four glycopeptides were detected, which contained N-glycans with b1,3-linked galactose residues as shown by digestion with X. manihotis b1,3-galactosidase ( Figure 8B ; see Supplemental Figure 7 online). This shows that GALT1 is a b1,3-galactosyltransferase catalyzing the formation of type 1 chains on oligosaccharide, glycopeptide, and glycoprotein substrates, including itself. These GALT1 products serve as substrates for FUT13, which leads to the synthesis of the Le a epitope on N-glycan substrates.
In plants, the predominant Lewis-type structure is (FA)(FA)XF (see Figure 1) . To assess the effect of b1,2-xylose and core a1,3-fucose residues on GALT1 activity, assays were performed using GnGnXF-PA and recombinant GALT1 and then analyzed by HPLC ( Figure 9A ). The presence of b1,2-xylose and core a1,3-fucose did not have any major effect on GALT1 activity, the specific activity for GnGnXF-PA (2.8 pmol/min/mg) being comparable to the one for GnGn-PA. The reaction products were subsequently incubated with recombinant FUT13 and GDPfucose and analyzed by LC-MS (the FUT13 product peaks could not be sufficiently separated by HPLC). Peaks with masses of 1981.7 and 2289.8 D were clearly detectable that represent (FA)GnXF/Gn(FA)XF-PA and (FA)(FA)XF-PA, respectively ( Figure   Figure 6 . Recombinant GALT1 Modifies Glycopeptide and N-Glycan Substrates with b1,3-Linked Galactose Residues.
(A) Immunoblot of purified recombinant GALT1, with (þ) and without (À) PNGase F digestion. (B) Dabsylated GnGn glycopeptide (m/z ¼ 2061) was incubated with purified recombinant GALT1 in the presence of the donor substrate UDPgalactose and analyzed by MALDI-TOF MS. In the bottom panel, the acceptor substrate (S) is shown as a control. Asterisks mark substrate fragmentation peaks. (C) GnGn-PA was incubated either with recombinant GALT1 or recombinant Mm-B3GALT1 and UDP-galactose. The reaction products of GALT1 coeluted with the Mm-B3GALT1 products. (D) Reaction products from the GALT1 assay shown in (C) were incubated with different b-galactosidases prior to rechromatography. X.m. galactosidase, b1,3-galactosidase from X. manihotis; A.o. galactosidase, A. oryzae b1,4-/b1,6-specific galactosidase.
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The Plant Cell 9B). This demonstrates that the combination of GALT1 and FUT13 is capable of producing the Le a -containing N-glycans typically found on plant glycoproteins.
Generation and Characterization of GALT1 RNA Interference and T-DNA Insertional Mutants
To further investigate the involvement of GALT1 in the synthesis of Le a structures, a reverse genetic approach was used. To this end, a mutant line (galt1-1) homozygous for a T-DNA insertion in the GALT1 gene ( Figure 10A , SAIL 170_A08) was isolated ( Figure  10B ). Sequencing of the T-DNA/genomic DNA boundaries revealed a single insertion in intron 4, resulting in the deletion of 36 bp. As a consequence, the intron 4/exon 5 splice site was destroyed, which leads to the absence of functional GALT1 transcripts as confirmed by RT-PCR ( Figure 10B ). As an alternative approach, an RNA interference (RNAi) construct ( Figure  10C ) was generated, which harbored 422 bp from the GALT1 cDNA (corresponding to exons 5 and 6) in sense and antisense orientations. Transgenic Arabidopsis plants were screened for reduced levels of GALT1 transcripts, and one RNAi line (galt1 RNAi ), which displayed the lowest amount of GALT1 mRNA ( Figure 10D ), was selected for further analysis. Total protein (B) GnGn-transferrin (GnGn-Tf) was incubated first with recombinant GALT1 and UDP-galactose and then with recombinant FUT13 and GDPfucose. As controls the acceptor substrate (GnGn-Tf), the donor substrates (UDP-galactose and GDP-fucose), or the glycosyltransferases (GALT1 and FUT13) were omitted in different combinations. The samples were subjected to SDS-PAGE under reducing conditions, and after blotting, Le a epitopes were detected using JIM84 antibodies. Tf, transferrin; Tf*, b1,3-galactosylated contaminant present in the transferrin sample used in this experiment. Note that GALT1 itself serves also as a substrate for FUT13. (A) Recombinant GALT1 (5 mg) was incubated (16 h, 378C) in 30 mL of 50 mM sodium citrate buffer, pH 4.5, either in the absence (lane 1) or presence of 42 milliunits (mU) of b1,3-galactosidase (lane 2) or 150 mU of b1,4-/b1,6-galactosidase (lane 3). Aliquots (2.5 mg GALT1) were then treated (16 h, 308C) with recombinant FUT13 (5 mg) in 50 mL of 100 mM MES buffer, pH 7.0, containing 0.5 mM GDP-fucose. The samples were then subjected to immunoblotting analysis with antibodies to the Le a epitope (JIM84) or to the enterokinase cleavage site present in recombinant GALT1 (anti-EK). All samples contain a GALT1 fragment (GALT1*) that fails to react with anti-EK antibodies.
(B) Recombinant GALT1 (5 mg) was excised from a Coomassie bluestained SDS-PAGE gel and subjected to tryptic digestion and subsequent MS analysis to identify glycopeptides with terminal galactose residues. To distinguish between the isobaric structures Man4GnF and b1,3-galactosylated AMF/MAF, a control sample (right panel) was digested with X. manihotis b1,3-galactosidase (X.m.). This confirmed that the peak with the mass of 2672.1 D consists mainly of the b1,3-galactosylated structure AMF/MAF, with the b1,3-galactosidase-insensitive fraction probably representing Man4GnF. The relevant part of the mass spectrum for glycopeptide T 279 SSTSLQSNTSR 290 is shown. The complete mass spectra of this and other GALT1 glycopeptides are included in Supplemental Figure 7 online.
extracts from stems of mutant lines galt1-1 and galt1 RNAi were subjected to immunoblots using JIM84. Both lines did not display a detectable signal with JIM84, whereas in wild-type and 35S:GALT1 plants, a strong staining was visible ( Figure 10E ). This finding was confirmed by MS N-glycan analysis. In contrast with wild-type plants and the overexpression line 35S:GALT1, no Le a -containing peaks were found in extracts of galt1-1 and galt1 RNAi stems (see Supplemental Figure 8 online). This provides Figure 9 . GALT1 Uses GnGnXF as a Substrate.
(A) The typical complex plant N-glycan substrate GnGnXF-PA was incubated with GALT1 and UDP-galactose to show that this b1,2-xylose and core a1,3-fucose containing N-glycan can act as an acceptor structure for GALT1. Three peaks were detected (GnA 3 XF-PA, A 3 GnXF-PA, and A 3 A 3 XF-PA), which coeluted with standards obtained by incubation of the substrate with Mm-B3GALT1. (E) Protein gel blot in which proteins were extracted from stems, and 10 mg were subjected to SDS-PAGE under reducing conditions. Detection was performed either with JIM84 or with anti-HRP antibodies, which recognize b1,2-xylose and core a1,3-fucose residues on N-glycans, as a loading control. 
Subcellular Localization of GALT1
The Golgi apparatus is not only a central sorting point within the secretory pathway. This compartment also plays a central biosynthetic role in processing of complex carbohydrate structures. The Golgi is the site of maturation of glycoprotein-bound N-glycans, and the subcellular location of many N-glycan processing enzymes has been determined to be in the Golgi (Dirnberger et al., 2002; Saint-Jore-Dupas et al., 2006; Strasser et al., 2006 ). An indication that GALT1 is also located in this subcellular compartment was provided by the observation that Le a structures have been detected in the Golgi by immunostaining using JIM84 (Horsley et al., 1993; Fitchette et al., 1999) . To investigate the subcellular location of GALT1, a GFP fusion construct was generated. This fusion protein encompasses the cytoplasmic tail, the predicted transmembrane domain, and the putative stem region (CTS) of GALT1. For many Golgi N-glycosylation enzymes, it has been demonstrated that the CTS region is sufficient to retain a reporter molecule in the plant Golgi (Essl et al., 1999; Dirnberger et al., 2002; Saint-Jore-Dupas et al., 2006; Strasser et al., 2006) . GALT1-GFP was transiently expressed in Nicotiana benthamiana leaf epidermal cells, and confocal laser scanning microscopy revealed fluorescence in small mobile vesicles similar as previously found for other Golgilocated enzymes ( Figures 11A and 11D ) (e.g., Strasser et al., 2006) . To further investigate whether this labeling corresponds to Golgi structures, GALT1-GFP was coexpressed with a Golgi marker construct consisting of the CTS region of rat a2,6-sialyltransferase fused to red fluorescent protein (ST-mRFP; Runions et al., 2006) . Both GALT1-GFP and ST-mRFP accumulated in the Golgi and exhibited significant colocalization, since 98% of the GALT1-GFP-containing structures were also positive for ST-mRFP ( Figures 11A to 11C ). Since it has been suggested that some N-glycosylation enzymes are located in the Golgi as well as in the ER (Saint-Jore-Dupas et al., 2006), GALT1-GFP was coexpressed with the ER marker YFP-HDEL ( Figure 11E ; Irons et al., 2003) . No significant colocalization of these two fluorescent proteins was observed ( Figure 11F ). This indicates that GALT1 is exclusively located in the Golgi apparatus, which is consistent with the proposed physiological action of the enzyme.
DISCUSSION
GALT1: An Enzyme Indispensable for the Biosynthesis of Le a Epitopes in Plants
We provide three lines of evidence for the cloning of a plant b1,3-galactosyltransferase (GALT1) indispensable for the biosynthesis of Le a structures on complex N-glycans: (1) overexpression of the GALT1 gene leads to the formation of Le a epitopes in tissues that normally do not synthesize detectable levels of the epitope; (2) recombinant expression of GALT1 in insect cells leads to an active enzyme capable of transferring Figure 11 . GALT1-GFP Accumulates in the Golgi.
N. benthamiana leaf epidermal cells transiently expressing GALT1-GFP ([A] and [D]), ST-mRFP (B), and YFP-HDEL (E) and the corresponding overlays of the images ([C] and [F]).
The punctate fluorescence of GALT1-GFP and its colocalization with ST-mRFP strongly indicates that GALT1-GFP accumulates in the Golgi, which is in good agreement with its proposed physiological action. Bars ¼ 10 mm. b1,3-Galactosyltransferasegalactose residues in b1,3-linkage to terminal GlcNAc residues present on N-glycans; and (3) inactivation of the GALT1 gene leads to a loss of Le a structures in planta. This demonstrates that GALT1 is both sufficient and essential for the initiation of Le a biosynthesis in plants. With GALT1, the last elusive enzyme involved in the formation and processing of complex plant N-glycans has been identified, which thus completes the molecular characterization of the pathway of complex N-glycan biosynthesis (see Supplemental Figure 1 
online).
GALT1: a Novel b1,3-Galactosyltransferase with a Unique Architecture GALT1 is classified as a member of family GT31 in the CAZy database, which contains 20 Arabidopsis sequences with significant similarity to mammalian B3GALTs. Phylogenetic analysis indicates that GALT1 belongs to a subfamily (subfamily 1) of six Arabidopsis proteins. However, no information is as yet available on the physiological functions of any other member of subfamily 1. The same applies to the other 14 B3GALT-like Arabidopsis proteins present in CAZy family GT31. None of them seems to be involved in N-glycan maturation. However, it can be envisaged that some of these B3GALT candidates participate in processes such as the biosynthesis of arabinogalactan proteins (Tan et al., 2004) or other cell wall components (Reid, 2000) .
In addition to the galactosyltransferase domain, all members of subfamily 1 contain a putative galactoside binding lectin domain with similarity to human galectins (Ackerman et al., 2002) . Interestingly, such a lectin domain is not present in mammalian B3GALTs (Hennet, 2002) . However, a C-terminal lectin domain is present in various mammalian polypeptide GalNAc-transferases (Hassan et al., 2000) . For the latter enzymes, it has been suggested that binding of the lectin domain to GalNAc-modified substrates serves to modulate their catalytic properties. However, the domain organization of subfamily 1 members with an N-terminal lectin domain and a C-terminal catalytic domain differs from that of polypeptide GalNAc-transferases. Hence, the function of the putative lectin domain of GALT1 remains to be determined.
Le a : A Tissue-Specific Structural Element of Complex Arabidopsis N-Glycans
It has been previously reported that glycoproteins from Arabidopsis and other members of the Brassicaceae lack Le a structures (Fitchette et al., 1999; Rayon et al., 1999; Wilson et al., 2001b) . In this study, we have clearly shown that Arabidopsis does contain glycoproteins with Le a moieties, which is in good agreement with results obtained by Jin et al. (2001) and Lé onard et al. (2002) , reporting the presence of Le a epitopes in Arabidopsis root tips and seedlings, respectively. Furthermore, our analyses revealed that Le a structures are organ-specifically expressed in Arabidopsis, with undetectable amounts in mature rosette leaves and relatively high levels in stems. The tissue specificity of this modification, an unprecedented observation for plant N-glycans, accounts for previous failures to detect the presence of Le a -containing N-glycans in Arabidopsis, since most of the earlier studies were performed on leaves (Fitchette et al., 1999; Rayon et al., 1999) .
Two different enzymes are involved in the biosynthesis of Le a structures, GALT1 and FUT13. It has been speculated earlier that the scarcity of Le a structures in Arabidopsis might be due to the absence of a functional FUT13 protein (Wilson et al., 2001c) . However, this assumption has been discarded with the identification of an enzymatically active Arabidopsis FUT13 (Lé onard et al., 2002) . This is in good agreement with our finding that overexpression of FUT13 does not lead to elevated Le a levels in Arabidopsis leaves, indicating that this enzyme is not the limiting factor in Le a biosynthesis in this organ. Our data indicate that GALT1 rather than FUT13 is the rate-limiting enzyme. This is supported by the following lines of evidence: (1) GALT1 is expressed in a tissue-specific manner, and its expression levels correlate with the Le a levels of the respective organs; (2) overexpression of GALT1 increases the occurrence of Le a epitopes in tissues with otherwise low Le a contents (e.g., leaves); (3) the catalytic proficiency of GALT1, at least in vitro, is rather low compared with other plant glycosyltransferases (Bencú r et al., 2005; Strasser et al., 2005) ; (4) while the activities of most other glycosyltransferases involved in N-glycan processing can be readily measured in plant extracts (e.g., Staudacher et al., 1995; Palma et al., 2001; Lé onard et al., 2002; Strasser et al., 2004b) , direct detection of endogenous GALT1 activity has not yet been achieved.
Even in 35S:GALT1 organs with relatively high Le a levels (e.g., stems), only a small fraction of N-glycans carries this modification. This could be simply due to the rather low specific activity of GALT1. However, overexpression of its far more active mouse counterpart Mm-B3GALT1 (Hennet et al., 1998; Zhou et al., 1999) led to similar low Le a levels as found in 35S:GALT1 plants. This suggests that GALT1 is not the sole factor limiting the occurrence of Le a epitopes on plant glycoproteins. Possible other contributing factors could be the in situ supply with the GALT1 donor substrate UDP-galactose (Seifert, 2004) or the limited availability of appropriate acceptor substrates (i.e., N-glycans with terminal GlcNAc residues). Given the complex architecture of the GALT1 protein, it is also possible that structural constraints permit the enzyme to act only on a small subset of endogenous glycoproteins. This is substantiated by the fact that until now only few purified plant glycoproteins have been found to carry Le a epitopes (Fitchette-Lainé et al., 1997; Melo et al., 1997; Kimura et al., 2005) .
It is of interest that N-glycans with free terminal Galb1-3GlcNAc moieties occur only in very small quantities in plants (Wilson et al., 2001b) , including our 35S:GALT1 lines. This could be due to one of the following scenarios: (1) in situ modification of nascent Galb1-3GlcNAc structures by FUT13 is quick and quantitative; or (2) unmodified Galb1-3GlcNAc moieties are rapidly degraded due to the action of b-galactosidases (transient galactose), in analogy to the transient modification of plant N-glycans with terminal GlcNAc residues. In the latter case, GlcNAc residues added in the Golgi are quickly removed upon arrival of the respective glycoprotein in vacuolar compartments (Vitale and Chrispeels, 1984) . A similar scenario could be envisaged for the removal of galactose residues from N-glycans carrying terminal Galb1-3GlcNAc moieties.
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Subcellular Localization of GALT1
JIM84 binds specifically to the Le a epitope and has been used for many years as a Golgi marker (Horsley et al., 1993; Fitchette et al., 1999) . This epitope has been detected in the Golgi apparatus of Arabidopsis cells by immunofluorescence and immunogold staining (Jin et al., 2001; Lé onard et al., 2002) , suggesting that the enzymes responsible for its formation are also located in this subcellular compartment. We have now obtained good evidence that GALT1 resides within the Golgi apparatus. A fusion protein of the 60 N-terminal amino acids of GALT1 and GFP displayed significant colocalization with a Golgi marker. This indicates that the N-terminal part of GALT1 consisting of its cytoplasmic tail (C), the single transmembrane domain (T), and a putative stem region (S) is sufficient for the proper subcellular localization of GALT1. The pivotal role of the CTS region for Golgi targeting and retention has been previously demonstrated for other plant N-glycosylation enzymes with a similar type II transmembrane protein topology (Essl et al., 1999; Dirnberger et al., 2002; Saint-Jore-Dupas et al., 2006; Strasser et al., 2006) . Thus, our findings correspond well with previous studies and with the proposed physiological action of the enzyme.
Properties of GALT1-Deficient Plants
Surprisingly little is still known about the function of N-glycans in plants. In mammals, complex N-glycans regulate a diversity of biological processes by modulating receptor-ligand interactions, for example, during embryonic development (Haltiwanger and Lowe, 2004) . In Arabidopsis, deficiencies in ER-resident N-glycosylation enzymes cause strong developmental phenotypes (Boisson et al., 2001; Burn et al., 2002; Gillmor et al., 2002) , which are probably related to the quality control function of N-glycans during protein folding in this compartment. By contrast, Arabidopsis mutants that completely lack complex N-glycans and thus also Le a structures are viable and display no obvious phenotype under standard growth conditions (von Schaewen et al., 1993) . Hence, it comes at no surprise that Arabidopsis plants with an inactivated GALT1 gene are normal with respect to morphology and growth rate. Similar results have been previously reported for other Golgi-resident enzymes acting at late stages during N-glycan maturation (Strasser et al., 2004a . However, it can be envisaged that plants with altered complex N-glycosylation might display conditional phenotypes, for example, under certain biotic or abiotic stress conditions. Such conditional phenotypes have been recently described for Caenorhabditis elegans mutants with modified complex N-glycans (Shi et al., 2006) . The GALT1-deficient Arabidopsis lines are valuable tools to establish the impact of Le a -containing N-glycans on the response of plants to various stress conditions and thus will help to elucidate the still unknown physiological function(s) of these oligosaccharides.
METHODS
Plant Materials and Growth Conditions
Wild-type plants of Arabidopsis thaliana (ecotype Columbia ) and transgenic plants were grown as described previously (Strasser et al., 2004a) . Nicotiana benthamiana plants were grown in a growth chamber at 228C with a 16-h-light/8-h-dark photoperiod. Arabidopsis cgl1 seeds were obtained from the Nottingham Arabidopsis Stock Centre (ID N6192; http://arabidopsis.info/).
Immunoblots from Arabidopsis Organs
Plant material was ground in liquid nitrogen, resuspended in PBS (137 mM NaCl, 2.7 mM KCl, 10 mM Na 2 HPO 4 , and 2 mM KH 2 PO 4 , pH 7.4) supplemented with 1% (v/v) Triton X-100, and cleared by centrifugation (two times for 3 min at 16,000g). The protein content was determined in the supernatant using a BCA protein assay kit (Pierce) and BSA as a standard. Ten to twelve micrograms of protein were subjected to 12% SDS-PAGE under reducing conditions and blotted onto Hybond Enhanced Chemiluminescence nitrocellulose membranes (GE Healthcare).
The blot was blocked in PBS containing 0.1% (v/v) Tween 20 and 3% (w/v) BSA for 1 h and incubated with a 1:40 dilution of JIM84 antibody (kindly provided by Paul Knox, University of Leeds, UK). The detection was performed after incubation in a 1:20,000 dilution of a horseradish peroxidase-conjugated goat anti-rat-IgM (m-chain) antibody (Jackson) with Supersignal West Pico Chemiluminescent Substrate (Pierce).
Total N-Glycan Analysis
Total N-glycan analysis was performed from 500 mg of leaves as described previously (Wilson et al., 2001b; Strasser et al., 2004a) . For stems and other organs, N-glycans were extracted from 20 mg of plant material by a modified version of the in-gel release method (Kolarich and Altmann, 2000) as described recently (Lé onard et al., 2005b) .
RT-PCR
Total RNA was purified from stems, siliques, cauline, and rosette leaves of Arabidopsis wild-type plants using a SV total RNA isolation kit (Promega). First-strand cDNA was synthesized from 500 ng of total RNA at 428C using oligo(dT) primers and AMV reverse transcriptase (Promega). Semiquantitative RT-PCR was performed using UBQ5-D/-U primers for ubiquitin and core a1,3-fucosyltransferase B (FucTB, At1g49710) FTB-9/-10 oligos as a control and the following GALT-specific primers: At1g26810-1F/-2R, At1g27120-1/-2, At1g74800-1/-2, At3g06440-1/-2, At4g21060-1/-2, and At5g62620-1/-2.
Ectopic Expression of cDNAs in Arabidopsis
cDNA for At1g27120 and At1g74800 was obtained from RIKEN (clones pda11283 and pda08691, respectively; http://rarge.gsc.riken.jp/ cdna/cdna_keyword.pl). The coding region was amplified with primers At1g27120-7/-8 and At1g74800-4F/-5R using Turbo Pfu polymerase (Stratagene) and inserted into the XbaI site of plant expression vector pPT2 . In pPT2, the expression of the DNA sequences is under the control of the cauliflower mosaic virus 35S promoter. The coding region of At1g26810 (GALT1) was amplified with BD Advantage 2 Polymerase (BD Biosciences) from cDNA obtained from siliques using the primers At1g26810-5/-6 and subcloned into pGEM-T vector (Promega). The GALT1 coding region was subsequently cloned into KpnI-BamHI sites of pPT2-gal, which is a derivative of pPT2 containing an additional KpnI cloning site. At3g06440 was amplified from leaf cDNA using primers At3g06440-3/-4 and BD Advantage 2 Polymerase and subcloned into pGEM-T. The coding region was excised with BamHIKpnI and ligated into pPT2-gal. The coding region of At5g62620 was amplified from cDNA of siliques using Turbo Pfu polymerase with primers At5g62620-5/-6 and cloned into the XbaI site of pPT2. We attempted unsuccessfully to amplify the At4g21060 open reading frame using oligos b1,3-Galactosyltransferasebased on the deposited cDNA sequence (NM_118224). Hence, we performed 59-RACE using a Smart RACE kit (BD Biosciences) and primer At4g21060-8R to obtain additional information about the At4g21060 cDNA. We found that the 59-end of the At4g21060 cDNA is different from the one deposited in the database. We designed oligo At4g21060-14F based on the new 59-end, and in combination with oligo At4g21060-10R, we could amplify the open reading frame (EF428438), which was cloned into the XbaI site of pPT2. The construct for Mm-B3GALT1 expression was obtained by amplification of the Mm-B3GALT1 coding region from mouse genomic DNA using oligos MGAL-F/-R and ligation into the XbaIBamHI sites of pPT2. For expression of FUT13, the open reading frame was amplified from leaf cDNA with primers AthFTC-7F/-2R and subcloned using a ZERO Blunt TOPO PCR cloning kit. The coding region was removed by XbaI-BglII digestion and inserted into the XbaI-BamHI sites of vector pPT2. All inserts were sequenced using a BIG Dye Termination Cycle sequencing kit (Applied Biosystems) to rule out the presence of mutations in the amplified sequences.
To obtain the 59-and 39-untranslated regions of GALT1 mRNA, 59-and 39-RACE reactions were performed using a Smart RACE kit and reverse primers At1g26810-18R and At1g26810-3R (59-RACE) and forward primer At1g26810-19F (39-RACE) .
Generation and Screening of Overexpression Lines
The transgenic expression lines (35S:At1g27120, 35S:At1g74800, 35S:At3g06440, 35S:At4g21060, 35S:At5g62620, 35S:GALT1, 35S:MmB3GALT1, and 35S:FUT13) were generated by floral dipping of Col-0 wild-type plants with agrobacteria containing the pPT2 constructs as described . Selection of transgenic lines was performed on basal Murashige and Skoog medium containing kanamycin. Positive seedlings were transferred to soil and screened by PCR for the presence of the expression construct and by RT-PCR using a genespecific forward primer and the universal reverse primer pPT2-1 binding to the untranslated 39-region of the RNA. For each line, 10 to 25 individuals were then subjected to protein gel blotting analysis using JIM84.
Expression of GALT1, Mm-B3GALT1, and FUT13 in Insect Cells
The N-terminal deletion construct of GALT1 containing amino acids 31 to 643 was generated by PCR using primers 15F1-Pst/15R1-Kpn. The PCR product was cleaved with PstI and KpnI restriction enzymes and ligated into pVTBacHis1 baculovirus transfer vector, digested with the same enzymes. In this construct, the truncated GALT1 protein is placed downstream of the melittin signal peptide, a 6xHis tag, and an enterokinase cleavage site (Bencú r et al., 2005) . Fragments encoding N-terminally truncated versions of Mm-B3GALT1 (amino acids 34 to 326) and FUT13 (amino acids 32 to 401) were generated and subcloned essentially as above using primers MGAL-4F/-5R (Mm-B3GALT1) and primers AthFTC-8F/-11R (FUT13, At1g71990). Expression in Spodoptera frugiperda Sf21 cells, purification and quantification of recombinant proteins, and enzymatic deglycosylation of GALT1 using PNGase F (peptide N-glycosidase F; Roche) were performed using previously published procedures (Bencú r et al., 2005; Strasser et al., 2006) with minor modifications. Recombinant GALT1 was detected on immunoblots with a mouse monoclonal antibody raised to the enterokinase recognition sequence (anti-EK; Invitrogen).
GALT1 Activity Assays
For GALT1 enzyme activity assays, a dabsylated GnGn-glycopeptide with N-glycans carrying two nonreducing terminal GlcNAc residues was used as a substrate. The standard reaction mixture consisted of 10 mL (0.55 to 0.98 mg/mL) purified GALT1, 50 mM acceptor substrate, 1 mM UDP-galactose, 10 mM MnCl 2 , and 0.1 M MES buffer, pH 6.8, in a total volume of 20 mL. After incubation for 20 h at 308C, the glycopeptides were purified from the assay mixture using 10 mg of C18 reversed phase matrix previously equilibrated with 5% (v/v) acetonitrile and eluted with 40% (v/v) acetonitrile plus 10% (v/v) isopropanol before analysis by MALDI-TOF MS. For assays with pyridylaminated (PA) substrates, purified GALT1 was incubated with 5 mM GnGn-PA or GnGnXF-PA as acceptor substrate along with 1 mM UDP-galactose and 10 mM MnCl 2 in 0.1 M MES buffer, pH 6.8, for 16 h at 308C. Samples were analyzed by HPLC using a porous graphitic carbon column (Thermo Hypersil Keystone-HYPERCARB) with the dimensions 150 3 3 mm and a particle size of 5 mm. Samples were eluted with 0.3% (v/v) formic acid (titrated to pH 3.0 with NaOH) as buffer A and 95% (v/v) acetonitrile in water as buffer B at a flow rate of 0.8 mL/min. Gradients (35 min) from 10 to 20% and 15 to 25% buffer B were applied for separation of A 3 Gn/GnA 3 and A 3 GnXF/GnA 3 XF isomers, respectively. Control assays with Mm-B3GALT1 were performed as described for GALT1. The identity of the Mm-B3GALT1 product peaks was verified by LC-MS analysis and by sequential exoglycosidase digestion using jack bean (Canavalia ensiformis) b-hexosaminidase (Sigma-Aldrich) and Xanthomonas manihotis b1,3-galactosidase (NEB) followed by rechromatography on a C18 reversed phase column as previously described (Kubelka et al., 1994) .
Activity Assays Using Transferrin
Human transferrin (Sigma-Aldrich) was converted to the GnGn-glycoform (GnGn-Tf) by neuraminidase (Sigma-Aldrich; from Clostridium perfringens) and Aspergillus oryzae b-galactosidase (Zeleny et al., 1997 ) treatment as described (Bencú rová et al., 2004) . Two micrograms of GnGn-Tf was first incubated overnight at 308C in 12.5 mM MnCl 2 , 125 mM MES buffer, pH 7.0, and 9.8 mg of purified recombinant GALT1 in the presence or absence of 0.5 mM UDP-galactose in a total volume of 20 mL. Subsequently, samples were incubated with 2.7 mg of FUT13 in 10 mM MnCl 2 , 0.1 M MES buffer, pH 7.0, and 0.5 mM GDP-fucose overnight at 308C in a total volume of 25 mL. Modified Tf proteins (0.1 mg) were then subjected to 12% SDS-PAGE under reducing conditions, blotted onto a nitrocellulose membrane, and incubated with JIM84 antibody as described above.
LC-MS Analysis of Tryptic Glycopeptides
Purified recombinant GALT1 (5 mg) from insect cells was separated by SDS-PAGE (10% polyacrylamide) under reducing conditions, and polypeptides were detected by Coomassie Brilliant Blue staining. The 80-kD band was excised from the gel, destained, carbamidomethylated, in-gel trypsin digested, and analyzed as described (Kolarich and Altmann, 2000; Kolarich et al., 2006) .
Digestions with b-Galactosidases
Degalactosylation experiments were performed with two different b-galactosidases. One b-galactosidase was purified from A. oryzae and found to selectively remove b1,4-and b1,6-linked galactose residues (Zeleny et al., 1997) . The other enzyme used was the commercially available recombinant b1,3-galactosidase from X. manihotis. All digestions were done in 50 mM sodium citrate, pH 4.5, for 16 h at 378C, using either 14 to 42 mU of b1,3-galactosidase or 150 mU of b1,4-/b1,6-galactosidase. One milliunit is the amount of enzyme causing the liberation of 1 nmol of 4-nitrophenol per minute using 5 mM pNP-b-Gal (Sigma-Aldrich) as substrate.
Generation and Screening of T-DNA Insertion and RNAi Lines
A GALT1 T-DNA insertion line (SAIL_170_A08) was obtained from the Nottingham Arabidopsis Stock Centre, and lines homozygous for the 12 of 15
The Plant Cell insertion were identified by PCR using one gene-specific primer (At1g26810-1F or At1g26810-3R) and a T-DNA left border-specific primer (LBsail2) and verified by sequencing. RNA was extracted from leaves of homozygous T-DNA insertion lines, and the absence of functional GALT1 transcripts was verified by RT-PCR with At1g26810-1F/-3R primers and UBQ5-D/-U as control primers.
To construct the GALT1 RNAi vector, the intron 2 (XTI2) sequence from the Arabidopsis b1,2-xylosyltransferase (At5g55500) was PCR amplified from genomic DNA with primers ARA-XTI2-fw/-rv, BamHI-KpnI digested, and ligated into BamHI-KpnI cut vector pUC18 to create puc18XTI2. A 422-bp fragment corresponding to exons 4 and 5 of the GALT1 gene was PCR amplified using primers At1g26810-9F/-10R, XbaI-BglII cut, and inserted into the XbaI-BamHI site of puc18XTI2 to create puc18XTI2-GALT1-s. To amplify the 422-bp antisense GALT1 fragment, PCR was performed with primers At1g26810-11F/-12R. The PCR product was KpnI-EcoRI digested and ligated into KpnI-EcoRI cut puc18XTI2-GALT1-s to create puc18XTI2-GALT1-sas. Subsequently, the senseintron-antisense cassette was removed by XbaI-BamHI digestion and cloned into XbaI-BamHI cut plant expression vector pPT2 to create pPT2-GALT1-RNAi. Transgenic Arabidopsis RNAi lines were generated by floral dipping of Col-0 plants as described above. The insertion of the RNAi construct into the plant genome was monitored by PCR from genomic DNA with the primers ARA-XTI2-fw/pPT2-1. Changes in the amount of GALT1 transcript in stems were analyzed by RT-PCR with GALT1 primers At1g26810-1F/-2R and core a1,3-fucosyltransferase B with primers FTB-9/-10 as a control. Protein gel blot analysis was performed using JIM84 as described above or anti-HRP antibody as described previously (Strasser et al., 2004a) .
Subcellular Localization
The GALT1-CTS region was amplified from GALT1 cDNA using primers At1g26810-4F and At1g26810-13R and ligated into BamHI-linearized p20F vector. Five-to six-week-old N. benthamiana plants were used for agroinfiltration experiments following the protocol of Batoko et al. (2000) . Briefly, the GALT1-GFP fusion construct was transformed into Agrobacterium tumefaciens strain UIA143 by electroporation. A single colony arising from each transformation was inoculated into 5 mL of LuriaBertani medium supplemented with 50 mg/mL of kanamycin and 25 mg/ mL of gentamycin and grown to stationary phase (20 to 24 h) at 298C with agitation. Three hundred microliters of bacterial culture was centrifuged and washed twice with infiltration buffer (50 mM MES, pH 5.6, 2 mM sodium phosphate, 0.5% [w/v] D-glucose, and 100 mM acetosyringone). For plant infiltration, resuspended bacteria were diluted to an OD 600 of 0.03 for GALT1-GFP, 0.03 for ST-mRFP, and 0.01 for YFP-HDEL. For coexpression of two different constructs, appropriate volumes of each bacterial suspension were mixed prior to infiltration. Diluted bacterial suspensions were injected through the stomata on the lower epidermal surface of fully expanded leaves using a 1-mL plastic syringe and gentle pressure. Fluorescent protein expression was analyzed in lower epidermal cells 2, 3, and 4 d after infiltration. Confocal imaging was conducted on a Leica TCS SP2 confocal laser scanning microscope. Images were obtained with a 340 1.25-numerical aperture or 363 1.4-numerical aperture oil immersion objective. GFP was imaged using a 488-nm argon laser line, and its emission was recorded from 505 to 535 nm, whereas mRFP was excited with a 543-nm HeNe laser line, and emission was collected at 605 to 635 nm. To perform colocalization with YFP-HDEL, the leaf discs were treated for 30 min with 12 mM latrunculin B (Sigma-Aldrich) according to Saint-Jore et al. (2002) to depolymerize actin. Subsequently, GFP was imaged using a 458-nm argon laser line, and its emission was recorded at 475 to 510 nm, while YFP was excited using a 514-nm argon laser line, and emission was collected at 535 to 590 nm. Postacquisition processing of images was done using Adobe Photoshop CS software.
Accession Numbers
Sequence data for GALT1 can be found in the GenBank/EMBL data libraries under accession number EF428439. The corrected sequence of At4g21060 cDNA is deposited in GenBank under accession number EF428438.
Supplemental Data
The following materials are available in the online version of this article. Supplemental Table 1 . 20 Arabidopsis Sequences from CAZy Family GT31 Contain a Galactosyltransferase Domain (pfam 0176).
Supplemental
Supplemental Table 2 . Primer Sequences Cited in Methods.
